Negash Abel Abera, Ferreira Ana, Asrat Daniel, Aseffa Abraham, Cools Piet, Van Simaey Leen, Vaneechoutte Mario, Bentley Stephen D, Lo Stephanie W
Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia.
Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK.
Microb Genom. 2025 Mar;11(3). doi: 10.1099/mgen.0.001376.
Despite the introduction of pneumococcal conjugate vaccines (PCVs), still remains an important cause of morbidity and mortality, especially among children under 5 years in sub-Saharan Africa. We sought to determine the distribution of serotypes, lineages and antimicrobial resistance of from carriage and disease among children presenting to health facilities, 5-6 years after the introduction of PCV10 in Ethiopia. Whole-genome sequencing (WGS) was performed on 103 (86 from nasopharyngeal swabs, 4 from blood and 13 from middle ear discharge) isolated from children aged <15 years at 3 healthcare facilities in Addis Ababa, Ethiopia, from September 2016 to August 2017. Using the WGS data, serotypes were predicted, isolates were assigned to clonal complexes, global pneumococcal sequence clusters (GPSCs) were inferred and screening for alleles and mutations that confer resistance to antibiotics was performed using multiple bioinformatic pipelines. The 103 . isolates were assigned to 38 serotypes (including nontypeable) and 46 different GPSCs. The most common serotype was serotype 19A. Common GPSCs were GPSC1 [14.6% (15/103), sequence type (ST) 320, serotype 19A], GPSC268 [8.7% (9/103), ST 6882 and novel STs; serotypes 16F, 11A and 35A] and GPSC10 [8.7% (9/103), STs 2013, 230 and 8804; serotype 19A]. The four invasive isolates were serotype 19A (=2) and serotype 33C (=2). Resistance to penicillin (>0.06 µg ml, CLSI meningitis cutoff) was predicted in 57% (59/103) of the isolates, and 43% (25/58) penicillin-binding protein allele combinations were predicted to be associated with penicillin resistance. Resistance mutations in () and/or (indel between fifty-sixth and sixty-seventh aa) were identified among 66% (68/103) of the isolates, whilst tetracycline () and macrolide ( and ) resistance genes were found in 46.6% (48/103), 20.4% (21/103) and 20.4% (21/103) of the isolates, respectively. Multidrug resistance (MDR) (≥3 antibiotic classes) was observed in 31.1% (32/103) of the isolates. GPSC1 and GPSC10 accounted for 46.8% (15/32) and 18.7% (6/32) of the overall MDR. Five to 6 years after the introduction of PCV10 in Ethiopia, the obtained from carriage and disease among paediatric patients showed diverse serotype and pneumococcal lineages. The most common serotype identified was 19A, expressed by the MDR lineages GPSC1 and GPSC10, which is not covered by PCV10 but is included in PCV13. Continued assessment of the impact of PCV on the population structure of in Ethiopia is warranted during and after PCV13 introduction.
尽管引入了肺炎球菌结合疫苗(PCV),但它仍然是发病和死亡的重要原因,尤其是在撒哈拉以南非洲5岁以下儿童中。我们试图确定在埃塞俄比亚引入PCV10后5至6年,到医疗机构就诊的儿童中,携带和患病肺炎球菌的血清型、谱系及抗菌药物耐药性分布情况。2016年9月至2017年8月期间,对从埃塞俄比亚亚的斯亚贝巴3家医疗机构中15岁以下儿童分离出的103株肺炎球菌(86株来自鼻咽拭子、4株来自血液、13株来自中耳分泌物)进行了全基因组测序(WGS)。利用WGS数据预测血清型,将分离株分配到克隆复合体,推断全球肺炎球菌序列簇(GPSC),并使用多个生物信息学管道筛选赋予抗生素耐药性的等位基因和突变。这103株肺炎球菌分离株被分配到38种血清型(包括不可分型)和46个不同的GPSC。最常见的血清型是19A。常见的GPSC有GPSC1[14.6%(15/103),序列类型(ST)320,血清型19A]、GPSC268[8.7%(9/103),ST 6882和新的ST;血清型16F、11A和35A]以及GPSC10[8.7%(9/103),ST 2013、230和8804;血清型19A]。4株侵袭性分离株为血清型19A(=2)和血清型33C(=2)。预测57%(59/103)的分离株对青霉素耐药(>0.06 µg ml,CLSI脑膜炎临界值),并且43%(25/58)的青霉素结合蛋白等位基因组合预计与青霉素耐药相关。在66%(68/103)的分离株中鉴定出肺炎链球菌青霉素结合蛋白(pbp)1a和/或pbp2x(第56至67位氨基酸之间的插入缺失)中的耐药突变,而分别在46.6%(48/103)、20.4%(21/103)和20.4%(21/103)的分离株中发现四环素(tet)和大环内酯类(ermB和mph(A))耐药基因。31.1%(32/103)的分离株观察到多重耐药(MDR,≥3类抗生素)。GPSC1和GPSC10分别占总体MDR的46.8%(15/32)和18.7%(6/32)。在埃塞俄比亚引入PCV10后5至6年,从儿科患者携带和疾病中分离出的肺炎球菌显示出多样的血清型和肺炎球菌谱系。鉴定出的最常见血清型是19A,由MDR谱系GPSC1和GPSC10表达,PCV10未涵盖该血清型,但PCV13包含该血清型。在引入PCV13期间及之后,有必要持续评估PCV对埃塞俄比亚肺炎球菌种群结构的影响。